Future number of people with diagnosed type 1 diabetes in Germany until 2040: an analysis based on claims data.


Journal

BMJ open diabetes research & care
ISSN: 2052-4897
Titre abrégé: BMJ Open Diabetes Res Care
Pays: England
ID NLM: 101641391

Informations de publication

Date de publication:
04 2023
Historique:
received: 29 09 2022
accepted: 24 03 2023
medline: 10 4 2023
entrez: 6 4 2023
pubmed: 7 4 2023
Statut: ppublish

Résumé

We aim to project the number of people with diagnosed type 1 diabetes in Germany between 2010 and 2040. We first estimate the age-specific and sex-specific incidence and prevalence of type 1 diabetes in Germany in 2010 using data from 65 million insurees of the German statutory health insurance. Then, we use the illness-death model to project the prevalence of type 1 diabetes until 2040. We alter the incidence and mortality underlying the illness-death model in several scenarios to explore the impact of possible temporal trends on the number of people with type 1 diabetes. Applying the prevalence from 2010 to the official population projections of Germany's Federal Statistical Office yields a total number of 252 000 people with type 1 diabetes in Germany in 2040 (+1% compared with 2010). Incorporating different annual trends of the incidence and mortality in the projection model results in a future number of people with type 1 diabetes between 292 000 (+18%) and 327 000 (+32%). For the first time in Germany, we provide estimates for the incidence, prevalence, and number of people with diagnosed type 1 diabetes for the whole German population between 2010 and 2040. The relative increase of the people with type 1 diabetes ranges from 1% to 32% in 2040 compared with 2010. The projected results are mainly influenced by temporal trends in the incidence. Ignoring these trends, that is, applying a constant prevalence to population projections, probably underestimates future chronic disease numbers.

Identifiants

pubmed: 37024151
pii: 11/2/e003156
doi: 10.1136/bmjdrc-2022-003156
pmc: PMC10083786
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMC Public Health. 2011 Oct 19;11:813
pubmed: 22011463
Diabetes Care. 1999 Mar;22 Suppl 2:B59-64
pubmed: 10097901
Diabet Med. 2004 May;21(5):456-9
pubmed: 15089790
Diabetologia. 2006 Sep;49(9):1996-8
pubmed: 16819610
Diabet Med. 2008 Oct;25(10):1178-86
pubmed: 19046196
Diabetes Metab. 2021 Jul;47(4):101205
pubmed: 33127474
Diabetes Care. 2022 Aug 1;45(8):1762-1771
pubmed: 35043145
BMJ Open Diabetes Res Care. 2023 Apr;11(2):
pubmed: 37024151
Gesundheitswesen. 2023 Mar;85(S 02):S119-S126
pubmed: 35654399
PLoS One. 2022 Mar 7;17(3):e0264739
pubmed: 35255104
Diabetologia. 2008 Dec;51(12):2187-96
pubmed: 18815769
BMC Res Notes. 2020 Apr 10;13(1):216
pubmed: 32299486
Diabet Med. 2013 Feb;30(2):161-9
pubmed: 23231526
N Engl J Med. 2017 Apr 13;376(15):1407-1418
pubmed: 28402770
JAMA. 2015 Jan 6;313(1):37-44
pubmed: 25562264
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Jan;63(1):93-102
pubmed: 31792553
Diabetes. 2005 Dec;54 Suppl 2:S62-7
pubmed: 16306342
BMJ Open Diabetes Res Care. 2020 May;8(1):
pubmed: 32475839
F1000Res. 2021 Jan 27;10:49
pubmed: 34136129
BMJ Open. 2021 Jan 6;11(1):e041508
pubmed: 33408205
Nephrol Dial Transplant. 2005 Mar;20(3):559-65
pubmed: 15671073
BMC Public Health. 2021 Jan 11;21(1):123
pubmed: 33430836
Diabet Med. 2013 Aug;30(8):999-1008
pubmed: 23506452
Lancet Diabetes Endocrinol. 2014 Nov;2(11):867-74
pubmed: 25128274
Diabetologia. 2019 Mar;62(3):408-417
pubmed: 30483858
J Gen Intern Med. 2007 Jul;22(7):1018-23
pubmed: 17436030
Nature. 2022 Mar 31;:
pubmed: 35361939
Diabet Med. 2019 Oct;36(10):1217-1225
pubmed: 30659656
BMJ Open Diabetes Res Care. 2021 Aug;9(1):
pubmed: 34400463
Am J Public Health. 2014 Apr;104(4):678-85
pubmed: 24524504
PLoS One. 2022 Apr 19;17(4):e0266809
pubmed: 35439266
J Community Hosp Intern Med Perspect. 2020 Sep 03;10(5):409-412
pubmed: 33235673
J Health Monit. 2019 Jun 27;4(2):29-49
pubmed: 35146246
Stat Med. 2013 May 30;32(12):2070-8
pubmed: 23034867
PLoS One. 2021 Dec 31;16(12):e0262171
pubmed: 34972197
Lancet. 2009 Jun 13;373(9680):2027-33
pubmed: 19481249

Auteurs

Dina Voeltz (D)

Biostatistics and Medical Biometry, Medical School OWL, Bielefeld University, Bielefeld, Germany dina.voeltz@uni-bielefeld.de.
Department of Statistics, Ludwig Maximilians University Munich, Munchen, Germany.

Ralph Brinks (R)

Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
Chair for Medical Biometry and Epidemiology, Witten/Herdecke University, Faculty of Health/School of Medicine, Witten, Germany.

Thaddäus Tönnies (T)

Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.

Annika Hoyer (A)

Biostatistics and Medical Biometry, Medical School OWL, Bielefeld University, Bielefeld, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH